Lymph node metastasis in breast cancer: common prognostic markers lack predictive value.
- 1 October 1998
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 5 (7) , 613-619
- https://doi.org/10.1007/bf02303831
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Does Information From Axillary Dissection Change Treatment in Clinically Node-Negative Patients With Breast Cancer?Annals of Surgery, 1997
- Predictors of axillary lymph node metastases in patients with T1 breast carcinomaCancer, 1997
- Current status of adjuvant systemic therapy for primary breast cancer: progress and controversyCA: A Cancer Journal for Clinicians, 1995
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- The need to reexamine axillary lymph node dissection in invasive breast cancerCancer, 1994
- Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancerThe Lancet, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct?Journal of Surgical Oncology, 1991
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985
- Patients with early breast cancer benefit from effective axillary treatmentBreast Cancer Research and Treatment, 1985